Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 772 participants.
Also called NCT00965406
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 772 participants
- Sponsor
- Registry
-
NCT00965406
-
- Other papers using this trial's data
- One-Year Outcome of Intensive Insulin Therapy Combined to Glucose-Insulin-Potassium in Acute Coronary Syndrome: A Randomized Controlled Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Tunisia
- Registry status
- Completed
Technical summary
Registry record NCT00965406. Randomized; single masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- GIK and intensive insulin therapy
- Lead sponsor
- University of Monastir
Record details
- Record id
cardio:ct-nct00965406- Content hash
ead08f70b77738cd1e8ea31a356084603ba614d47b9cad604a59f59a242acaca